An Israeli Covid drug which reportedly cured 30 cases of the disease in patients in a hospital, has been hailed by scientists as a ‘huge breakthrough’.
The EXO-CD24 substance was developed at the Ichilov Medical Centre in Tel Aviv and successfully completed its first phase of clinical trials on Friday.
The treatment was given to 30 patients with coronavirus, whose conditions ranged from moderate to severe.
Twenty-nine of the patients were then discharged from the hospital in the following three to five days, while one patient took slightly longer to recover.
A protein known as CD24 is delivered to the lungs by exosomes in the drug, which helps to rebalance the immune system and prevent it from overreacting to the virus.
Professor Nadir Arber originally designed EXO-CD24, which is breathed in as a gas and taken once every five days, in order to treat patients who had ovarian cancer.
“Even if the vaccines do their job, and even if there aren’t any new mutations, one way or another, the coronavirus will be staying with us,” Prof Arber told the news site Arutz Sheva.
“That’s why we developed this special medication. It’s been about half a year from the time the idea was hatched to the first human trials [being] conducted.”
Roni Gamzu, the director of the Ichilov Medical Centre, said that the research during phase one of the trial was “advanced and sophisticated and may save coronavirus patients”.
Culled from Yahoo